SonoMind Email Formats

Medical Equipment Manufacturing • • 1-10 Employees

Key Contact at SonoMind

Jeremy Bercoff

Chief Executive Officer

Company overview

Headquarters	XX
Website	sonomind.com
NAICS	3391
Founded	2024
Employees	1-10
Socials

About SonoMind

Sonomind is a medical device company specializing in non-invasive brain stimulation utilizing low-intensity focused ultrasound to treat drug-resistant depression and other neurological and psychiatric conditions. This portable device is the first to deliver precision transcranial ultrasound stimulation that is able to penetrate deep brain structures in an accurate, targeted and non-invasive manner. A custom-designed acoustic lens for each patient delivers low-intensity focused ultrasound, enabling ultrasound waves to pass through the skull and compensate for any distortion upon entering the brain. Located in Paris, France, Sonomind has a staff of ten, headed by CEO Jeremy Bercoff. The company leverages 25 years of research undertaken by Profs. Mickael Tanter and Jean-François Aubry at the Institut Physique pour la Médecine (Inserm, ESPCI Paris - PSL, CNRS). Sonomind has raised €2 million since inception

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Head

C-Suite

Employees by Department

SonoMind has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

SonoMind has never raised funding before.

Frequently asked questions

SonoMind is located in XX.

SonoMind was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

SonoMind has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at SonoMind

Jeremy Bercoff

Chief Executive Officer

4.8

40,000 users